About Pharmerit India Private Limited
Data last updated:
Pharmerit India Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Pharmerit International Lp. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 21 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U93090MH2018FTC318679. Its GSTIN is 27AAKCP2646N1ZU (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Tejas Manharlal Shah and Jennifer Means Stephens.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop – 8 Shilpa Trading Royal Accord Chakala Andheri (East) Tarun Bharat Rd, Mumbai, Maharashtra, India – 400099.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.39 Cr, a decline of 65% compared to the previous year. For the same year it recorded a net profit of ₹1.37 Cr (net margin 21.4%) and EBITDA of ₹1.99 Cr (EBITDA margin 31.1%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 12% over five years.
The company is associated with 1 brand: Pharmerit.
For more details, the company can be reached via its website pharmerit.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressShop – 8 Shilpa Trading Royal Accord Chakala Andheri (East) Tarun Bharat Rd, Mumbai, Maharashtra, India – 400099
- IndustryBusiness Outsourcing, Business & IT Consulting
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pharmerit India Private Limited
The main business activity of Pharmerit India is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pharmerit India Private Limited FY 2025 filings available
Pharmerit India Private Limited reported revenue of ₹6.39 Cr (down 65% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Pharmerit India Private Limited
Revenue fell 65% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 12%. EBITDA fell 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pharmerit India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.99 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.37 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pharmerit India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 31.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 21.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pharmerit India are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pharmerit India Private Limited
Pharmerit India Private Limited is compared with the companies closest to it by revenue in the Outsourcing industry (Consulting Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wise Finserv Private Limited | ₹6.41 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
| V N B Consulting Services Private Limited | ₹6.4 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Mumbai, Maharashtra, India |
| Samadhan Associates Limited | ₹6.4 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Lucknow, Uttar Pradesh, India |
| Strives Acht Labour Private Limited | ₹6.4 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Vadodara, Gujarat, India |
| Mudrika Secure Print and Pack Private Limited | ₹6.39 Cr (FY 2025) | •••• | •••• | 108.0% | •••• | Medchal Malkajgiri, Telangana, India |
| Pharmerit India Private Limited this company | ₹6.39 Cr (FY 2025) | •••• | •••• | -65.0% | •••• | Mumbai, Maharashtra, India |
| Dravidian Routes Private Limited | ₹6.39 Cr (FY 2024) | •••• | •••• | 126.0% | •••• | Udupi, Karnataka, India |
| Gematria Technologies Private Limited | ₹6.39 Cr (FY 2019) | •••• | •••• | 41.0% | •••• | New Delhi, Delhi, India |
| Corpsolutions Services Private Limited | ₹6.38 Cr (FY 2025) | •••• | •••• | -22.0% | •••• | Mumbai, Maharashtra, India |
| Octavo Solutions Private Limited | ₹6.38 Cr (FY 2025) | •••• | •••• | 97.0% | •••• | New Delhi, Delhi, India |
| Realval Private Limited | ₹6.38 Cr (FY 2025) | •••• | •••• | 51.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Pharmerit India by revenue in the Outsourcing industry (Consulting Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Pharmerit India Private Limited
Pharmerit India Private Limited is audited by VBG & Company for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VBG & Company | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Pharmerit India Private Limited
Pharmerit India has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tejas Manharlal Shah | Director | 29 Sep 2024 | 2 Years 0 Months | Current |
| Jennifer Means Stephens | Director | 21 Dec 2018 | 7 Years 9 Months | Current |
| Richard Jones | Director | 16 May 2025 | 1 Years 4 Months | Current |
Ownership and Shareholding of Pharmerit India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pharmerit India Private Limited
Pharmerit India Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Pharmerit India Private Limited
Pharmerit India operates one associated brand: Pharmerit. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides comprehensive market access and data management solutions for healthcare and related industries. | pharmerit.com |
Employees and EPFO Compliance at Pharmerit India Private Limited
Employment history and EPFO contributions of people linked to Pharmerit India.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pharmerit India Private Limited
Pharmerit India Private Limited has 11 board changes on record since 2018: 4 appointments and 7 cessations. The latest: Richard Jones ceased to be Additional Director on 29 Sep 2025.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Pharmerit India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pharmerit India Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pharmerit India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pharmerit India Private Limited
Pharmerit India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAKCP2646N1ZU | Maharashtra | Active | 03 Mar 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pharmerit India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmerit India Private Limited
Pharmerit India is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 21 December 2018 (8+ years old) and is registered under CIN U93090MH2018FTC318679.
Pharmerit India reported revenue of ₹6.39 Cr for FY 2025 (down 65% YoY).
Pharmerit India has 3 current directors:
- Tejas Manharlal Shah - Director
- Jennifer Means Stephens - Director
- Richard Jones - Director
Pharmerit India reported a net profit of ₹1.37 Cr (net margin 21.4%) and EBITDA of ₹1.99 Cr (EBITDA margin 31.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pharmerit India is 3% over three years and 12% over five years. In the latest year (FY 2025) revenue fell 65%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pharmerit India is 27AAKCP2646N1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Pharmerit India is U93090MH2018FTC318679. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmerit India was incorporated on 21 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Pharmerit India by revenue are Wise Finserv Private Limited, V N B Consulting Services Private Limited, Samadhan Associates Limited, Strives Acht Labour Private Limited, Mudrika Secure Print and Pack Private Limited and 5 more, all in the Outsourcing industry (Consulting Services).
Richard Jones ceased to be Additional Director on 29 Sep 2025. Richard Jones was appointed as Director on 16 May 2025. Amrita Mehta ceased to be Additional Director on 30 Sep 2024. Pharmerit India has 11 board changes on record in total.
Pharmerit India can be reached through the website pharmerit.com. Its registered office is in Mumbai, Maharashtra, India.